Peer-influenced content. Sources you trust. No registration required. This is HCN.

MDLinxThe Promising Potential of Nanotechnology in Breast Cancer Care

Nanoformulations including liposomes, nanofibers, nanocapsules, dendrimers, and nanoparticles are currently being developed as solutions to remaining obstacles in cancer care. Some have already shown evidence of their ability to prevent cancer cell proliferation, lessen the risk of recurrence, minimize the chance of post-chemotherapy metastasis, and improve breast implants’ performance through better cell growth scaffolding.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form